Radiopharm Theranostics Limited (RADX) Operating margin 2023–2025
Radiopharm Theranostics Limited (RADX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1050.6%FY2025 · since FY2023: -11796.1% → -1050.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1050.6% | +14726.6 pp |
| FY2024 | -15777.2% | -3981.1 pp |
| FY2023 | -11796.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RADX financial trends
RADX RevenueRADX Net incomeRADX Net marginRADX Gross profitRADX Gross marginRADX Operating incomeRADX Operating cash flowRADX Free cash flowRADX Capital expendituresRADX Return on equityRADX Stock buybacksRADX Dividends paidRADX Total assetsRADX Total liabilitiesRADX Shareholders’ equityRADX overview →